UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

BMC pregnancy and childbirth, 2022-12, Vol.22 (1), p.910-910, Article 910

2022

Volltextzugriff (PDF)

Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis

Osteoporosis international, 2011-12, Vol.22 (12), p.3067-3072

2011

Volltextzugriff (PDF)

Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only

International journal of hematology, 2011-06, Vol.93 (6), p.811-814

2011

Volltextzugriff (PDF)

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.1011-1016

2009

Volltextzugriff (PDF)

Long‐Term Clinical Outcomes in a Cohort of Adults With Childhood‐Onset Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2019-02, Vol.71 (2), p.290-301

2019

Volltextzugriff (PDF)

Therapeutic plasma exchange in pregnancy: A literature review

European journal of obstetrics & gynecology and reproductive biology, 2021-05, Vol.260, p.29-36

2021

Volltextzugriff (PDF)

Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.1075-1077

2009

Volltextzugriff (PDF)

POS0680 BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.585-585

2021

Volltextzugriff (PDF)

The addition of the sFlt-1/PlGF ratio to the protein/creatinine ratio in multiple pregnancy: Post-hoc analysis of the PREPARE cohort study

Pregnancy hypertension, 2024-06, Vol.36, p.101111-101111, Article 101111

2024

Volltextzugriff (PDF)

A breathtaking DRESS due to amoxicillin–clavulanate presenting as polymorphic eruption of the pregnancy

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.e436-e437

2018

Volltextzugriff (PDF)

Diagnosis and treatment of C3 glomerulopathy in a center of expertise

Netherlands journal of medicine, 2019-01, Vol.77 (1), p.10-18

2019

Volltextzugriff (PDF)

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1402-1403

2007

Volltextzugriff (PDF)

Azathioprine-induced eosinophilic myocarditis in a patient with ANCA-associated vasculitis

Clinical and experimental rheumatology, 2016-01, Vol.34 (3 Suppl 97), p.S146

2016

Volltextzugriff (PDF)

Efficacy of intraarticular infliximab in patients with chronic or recurrent gonarthritis: A clinical randomized trial

Arthritis and rheumatism, 2009-07, Vol.61 (7), p.974-978

2009

Volltextzugriff (PDF)

Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study

BMJ, 2003-07, Vol.327 (7407), p.131-132

International edition, 2003

Volltextzugriff (PDF)

POS0186 VOCLOSPORIN FOR LUPUS NEPHRITIS: RESULTS OF THE TWO-YEAR AURORA 2 CONTINUATION STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.325-325

2022

Volltextzugriff (PDF)

Belimumab after rituximab as maintenance therapy in lupus nephritis

Rheumatology (Oxford, England), 2014-11, Vol.53 (11), p.2122-2124

2014

Volltextzugriff (PDF)

OP0281 PHARMACODYNAMIC EFFECT OF SEQUENTIAL BELIMUMAB (BEL) AND RITUXIMAB (RTX) THERAPY IN PATIENTS (PTS) WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE PHASE 3, RANDOMISED, PLACEBO-CONTROLLED BLISS-BELIEVE STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.186-186

2022

Volltextzugriff (PDF)

FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

POS0185 BELIMUMAB DISRUPTS MEMORY B-CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.324-325

2022

Volltextzugriff (PDF)

OP0091 EXPANSION OF MYELOPEROXIDASE (MPO)-SPECIFIC IgM B CELLS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.61-61

2022

Volltextzugriff (PDF)

MO257BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.103-103

2020

Volltextzugriff (PDF)

THU0304 CLINICAL PRACTICE VARIATION BETWEEN ACADEMIC AND NON-ACADEMIC CENTERS IN THE MANAGEMENT OF ANCA ASSOCIATED VASCULITIS IN THE NETHERLANDS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.380-381

2020

Volltextzugriff (PDF)

1 – 25 von 460

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(431)
Mit Volltextzugriff
(399)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(147)
Physics
(133)
Biological And Medical Sciences
(114)
Humans
(92)
Medical Sciences
(92)
Physical Sciences
(86)
Male
(76)
Female
(64)
Pharmacology. Drug Treatments
(56)
Animals
(54)
Experiment
(49)
Particle Physics
(46)
Middle Aged
(45)
High Energy Physics - Experiment
(41)
Pharmacology & Pharmacy
(38)
Physics Of Elementary Particles And Fields
(37)
Physics, Particles & Fields
(36)
Adult
(34)
Aged
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study

Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis

Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation

Long‐Term Clinical Outcomes in a Cohort of Adults With Childhood‐Onset Systemic Lupus Erythematosus

Therapeutic plasma exchange in pregnancy: A literature review

Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies

POS0680 BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE

The addition of the sFlt-1/PlGF ratio to the protein/creatinine ratio in multiple pregnancy: Post-hoc analysis of the PREPARE cohort study

A breathtaking DRESS due to amoxicillin–clavulanate presenting as polymorphic eruption of the pregnancy

Diagnosis and treatment of C3 glomerulopathy in a center of expertise

Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

Azathioprine-induced eosinophilic myocarditis in a patient with ANCA-associated vasculitis

Efficacy of intraarticular infliximab in patients with chronic or recurrent gonarthritis: A clinical randomized trial

Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study

POS0186 VOCLOSPORIN FOR LUPUS NEPHRITIS: RESULTS OF THE TWO-YEAR AURORA 2 CONTINUATION STUDY

Belimumab after rituximab as maintenance therapy in lupus nephritis

OP0281 PHARMACODYNAMIC EFFECT OF SEQUENTIAL BELIMUMAB (BEL) AND RITUXIMAB (RTX) THERAPY IN PATIENTS (PTS) WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE PHASE 3, RANDOMISED, PLACEBO-CONTROLLED BLISS-BELIEVE STUDY

FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION

POS0185 BELIMUMAB DISRUPTS MEMORY B-CELL TRAFFICKING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

OP0091 EXPANSION OF MYELOPEROXIDASE (MPO)-SPECIFIC IgM B CELLS IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS

MO257BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS

MO251HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS PATIENTS

OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS

THU0304 CLINICAL PRACTICE VARIATION BETWEEN ACADEMIC AND NON-ACADEMIC CENTERS IN THE MANAGEMENT OF ANCA ASSOCIATED VASCULITIS IN THE NETHERLANDS

Suchergebnisse filtern